YU71202A - Lipopolisaharidi iz escherihie coli - Google Patents
Lipopolisaharidi iz escherihie coliInfo
- Publication number
- YU71202A YU71202A YU71202A YUP71202A YU71202A YU 71202 A YU71202 A YU 71202A YU 71202 A YU71202 A YU 71202A YU P71202 A YUP71202 A YU P71202A YU 71202 A YU71202 A YU 71202A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- lps
- extracted
- coli
- lipopolysaccharide
- escherichia coli
- Prior art date
Links
- 239000002158 endotoxin Substances 0.000 title abstract 5
- 229920006008 lipopolysaccharide Polymers 0.000 title abstract 5
- 241000588724 Escherichia coli Species 0.000 title abstract 4
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 238000006116 polymerization reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Pronalazak se odnosi na lipopolisaharide iz E. coli DSM 6601. Ovaj LPS se od do sada poznatih LPS-a iz E. coli posebno razlikuje po sadržaju fosforilizovanog šećera u osnovnom lancu i po stepenu polimerizacije lanca O. Lipoid A strukturno i biološki odgovara uobičajenom tipu za E.coli. Opisani LPS nije pogodan samo za identifikaciju soja coli, koji ga nosi, već istome daje i smanjenu patogenost, uz očuvanje njegovog imunomodulirajućeg dejstva.[The invention relates to lipopolysaccharides extracted from E. coli DSM 6601. This LPS differs from the known LPS extracted from E. coli in particular with regard to the phosphorylated sugar moiety of the core and to the degree of polymerization of the O-chain. The A lipoid corresponds structurally and biologically to the classic type of E. coli. The inventive LPS is not only suitable for identifying the coli strain which carries it, but also provides the latter with a reduced pathogenic capability, whilst retaining its immunomodulative effect.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10013539A DE10013539B4 (de) | 2000-03-20 | 2000-03-20 | Lipopolysaccharide aus Escherichia coli, Verfahren zu deren Herstellung und deren Verwendungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU71202A true YU71202A (sh) | 2006-01-16 |
Family
ID=7635468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU71202A YU71202A (sh) | 2000-03-20 | 2001-03-20 | Lipopolisaharidi iz escherihie coli |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6833451B2 (sh) |
| EP (1) | EP1266023A2 (sh) |
| JP (1) | JP2003528175A (sh) |
| KR (1) | KR20030047878A (sh) |
| CN (1) | CN1436245A (sh) |
| AP (1) | AP2002002622A0 (sh) |
| AU (2) | AU7389901A (sh) |
| BG (1) | BG107115A (sh) |
| BR (1) | BR0109392A (sh) |
| CA (1) | CA2402544A1 (sh) |
| CZ (1) | CZ20023469A3 (sh) |
| DE (1) | DE10013539B4 (sh) |
| EA (1) | EA005217B1 (sh) |
| EE (1) | EE200200537A (sh) |
| HK (1) | HK1053148A1 (sh) |
| HR (1) | HRP20020682A2 (sh) |
| HU (1) | HUP0204540A3 (sh) |
| IL (1) | IL151785A0 (sh) |
| IS (1) | IS6517A (sh) |
| MX (1) | MXPA02009215A (sh) |
| NO (1) | NO20024480L (sh) |
| NZ (1) | NZ520968A (sh) |
| PL (1) | PL368447A1 (sh) |
| SK (1) | SK13492002A3 (sh) |
| UA (1) | UA75068C2 (sh) |
| WO (1) | WO2001070756A2 (sh) |
| YU (1) | YU71202A (sh) |
| ZA (1) | ZA200207408B (sh) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030031684A1 (en) | 2001-03-30 | 2003-02-13 | Corixa Corporation | Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid a (3D-MLA) |
| DE10328669B4 (de) * | 2003-06-26 | 2005-12-01 | Pharma-Zentrale Gmbh | Plasmidfreier Klon des E. coli Stammes DSM 6601 |
| US20050191276A1 (en) * | 2003-11-25 | 2005-09-01 | Gregory Gurtner | Treatment of inflammatory bowel disease through induction of indoleamine 2.3-dioxygenase |
| US20050238651A1 (en) * | 2003-11-25 | 2005-10-27 | Gurtner Gregory J | Treatment of inflammatory bowel disease |
| WO2006025995A2 (en) * | 2004-07-27 | 2006-03-09 | The Regents Of The University Of California | Compositions and methods using md-2 mutants and chimeric proteins |
| CN100354428C (zh) * | 2005-01-13 | 2007-12-12 | 丁友玲 | 隧道式干热灭菌设备测试用内毒素指示剂的制备方法 |
| EP1961823B1 (en) * | 2005-11-28 | 2024-06-12 | Biomedical Research Group Inc. | Method for producing lipopolysaccharide and lipopolysaccharide |
| WO2011133595A1 (en) | 2010-04-19 | 2011-10-27 | Massachusetts Institute Of Technology | A polymer-nanostructure composition for selective molecular recognition |
| US20130066064A1 (en) * | 2010-05-20 | 2013-03-14 | Glaxosmithkline Biologicals S.A, | Novel process |
| CN105137073A (zh) * | 2015-08-06 | 2015-12-09 | 中国兽医药品监察所 | 牛布鲁氏菌胶体金抗体检测试纸条 |
| PL432842A1 (pl) * | 2020-02-10 | 2021-08-16 | Uniwersytet Warszawski | LPS do zastosowania w indukowaniu u osobnika tolerancji na alergeny pokarmowe wywołujące alergie pokarmowe zależne od IgE |
| CA3171408A1 (en) * | 2020-03-13 | 2021-09-16 | Martine Caroff | Detoxified lipopolysaccharides (lps), naturally non-toxic lps, and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19844191A1 (de) * | 1998-09-28 | 2000-03-30 | Pharma Zentrale Gmbh | Lipopolysaccharide aus Escherichia coli |
-
2000
- 2000-03-20 DE DE10013539A patent/DE10013539B4/de not_active Expired - Lifetime
-
2001
- 2001-03-20 AP APAP/P/2002/002622A patent/AP2002002622A0/en unknown
- 2001-03-20 HR HRP20020682 patent/HRP20020682A2/hr not_active Application Discontinuation
- 2001-03-20 AU AU7389901A patent/AU7389901A/xx active Pending
- 2001-03-20 HU HU0204540A patent/HUP0204540A3/hu unknown
- 2001-03-20 KR KR1020027012241A patent/KR20030047878A/ko not_active Abandoned
- 2001-03-20 CZ CZ20023469A patent/CZ20023469A3/cs unknown
- 2001-03-20 IL IL15178501A patent/IL151785A0/xx unknown
- 2001-03-20 US US10/239,254 patent/US6833451B2/en not_active Expired - Fee Related
- 2001-03-20 WO PCT/EP2001/003153 patent/WO2001070756A2/de not_active Ceased
- 2001-03-20 UA UA2002108256A patent/UA75068C2/uk unknown
- 2001-03-20 BR BR0109392-4A patent/BR0109392A/pt not_active IP Right Cessation
- 2001-03-20 EP EP01940260A patent/EP1266023A2/de not_active Withdrawn
- 2001-03-20 JP JP2001568957A patent/JP2003528175A/ja active Pending
- 2001-03-20 PL PL01368447A patent/PL368447A1/xx unknown
- 2001-03-20 EE EEP200200537A patent/EE200200537A/xx unknown
- 2001-03-20 HK HK03104380.7A patent/HK1053148A1/zh unknown
- 2001-03-20 SK SK1349-2002A patent/SK13492002A3/sk unknown
- 2001-03-20 AU AU2001273899A patent/AU2001273899B2/en not_active Ceased
- 2001-03-20 MX MXPA02009215A patent/MXPA02009215A/es unknown
- 2001-03-20 NZ NZ520968A patent/NZ520968A/en unknown
- 2001-03-20 CN CN01806916A patent/CN1436245A/zh active Pending
- 2001-03-20 CA CA002402544A patent/CA2402544A1/en not_active Abandoned
- 2001-03-20 EA EA200200997A patent/EA005217B1/ru not_active IP Right Cessation
- 2001-03-20 YU YU71202A patent/YU71202A/sh unknown
-
2002
- 2002-08-21 IS IS6517A patent/IS6517A/is unknown
- 2002-09-16 ZA ZA200207408A patent/ZA200207408B/xx unknown
- 2002-09-18 BG BG107115A patent/BG107115A/bg unknown
- 2002-09-19 NO NO20024480A patent/NO20024480L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU71202A (sh) | Lipopolisaharidi iz escherihie coli | |
| CA2196801A1 (en) | Novel vaccine adjuvant and vaccine | |
| AU2002314168A1 (en) | Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced mop-b expression | |
| DE69841437D1 (de) | Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren | |
| PL402939A1 (pl) | Kompozycja 3-0-deacylo-4'-monofosforylolipidu A | |
| DE69932425D1 (de) | Attenuierte salmonella mutanten, welche das vi-antigen konstant exprimieren | |
| EP1733735A3 (en) | Methods and products for inducing mucosal immunity | |
| CA2238640A1 (en) | Non-toxic mutants of pathogenic gram-negative bacteria | |
| PT1643861E (pt) | Composição nutricional líquida rica em fibras alimentares e rica em calorias para a saúde intestinal no doente idoso | |
| CA2477517A1 (en) | Color selection scheme for digital video watermarking | |
| GB9806449D0 (en) | Attenuated bacteria useful in vaccines | |
| AU2001273899A1 (en) | Lipopolysaccharides (LPS) extracted from escherichia coli | |
| AU2710097A (en) | Receptacle with variable dimensions | |
| NO20015108D0 (no) | Komplett fôr for fiskelarver og fremgangsmåte for fremstilling av det samme | |
| TW365519B (en) | Egg yolk phospholipid composition | |
| GR3018660T3 (en) | Nematode vaccine. | |
| EP1108433A3 (en) | Combination vaccine for enhancing immunity against brucellosis | |
| CA2285633A1 (en) | Bacterial plasmids | |
| ZA949562B (en) | Conjugates of hirudin and lipophilic compounds | |
| ES2177202T3 (es) | Productos de yeso. | |
| AU2002218232A1 (en) | L-threonine producing e. coli strain | |
| EP0309161A3 (en) | Antibiotic compounds | |
| GB2313547A (en) | Methods and compositions for sedating,anaesthetising and euthanising aquatic organisms | |
| EP0763982A4 (en) | NEW BIOEMULGATORS | |
| DK0858465T3 (da) | Protein med antitumorvirkning. |